Zydus Cadila’s Vaccine Gets Emergency Use nod form DCGI

Zydus Cadila’s three dose vaccine ZyCoV-D became sixth to get emergency use authorization from Drug Controller General of India (DCGA). It can be administered to anyone more than 12 years old.

ZyCoV-D is world’s first India’s indigenously developed DNA based needle-free vaccine for Covid-19.

Five others vaccines with emergency use approval are:

  1. Serum Institute’s Covishield
  2. Bharat Biotech’s Covaxin
  3. Russia’s Sputnik V,
  4. Moderna’s Vaccine
  5. Johnson and Johnson’s Vaccine

About ZyCoV-D

ZyCov-D is the world’s first DNA vaccine against infection with SARS-CoV-2. It is a “plasmid DNA” vaccine that uses a genetically engineered, non-replicating version of a type of DNA molecule known as a ‘plasmid’.

About Zydus Cadila

Cadila Healthcare is an Ahmedabad, Gujrat based multinational pharmaceutical company founded by Ramanbhai Patel in 1952. Zydus Pharmaceuticals (USA) Inc. is the US generic drug division of much larger company Zydus Cadila Healthcare. It has presence in more than 50 countries.



Related articles

The Advancements and Threats of AI: Analyzing the Benefits and Risks of ChatGPT and GPT-4

Artificial Intelligence (AI) has become increasingly popular in recent...

Hockey’s Jadoogar – Dhyan Chand

Dhyan Chand popularly known as hockey's jadoogar. Dhyan Chand...

Art and Literature of Middle Ages

Art during the Middle Ages was different based on...

Literature of Ancient India: Sanskrit Drama

The origin of Sanskrit drama is in obscurity; there...

The Bhakti Movement of the Medieval Age

The Bhakti Movement, one of the most remarkable features...
Previous article
Next article
Articles are written and edited by the Syskool Staffs.